ASXL3 and Bohring-Opitz syndrome: They found that some patients with clinical manifestations resembling those of Bohring-Opitz syndrome (BOS), which is associated with de novo truncating or missense mutations in the ASXL1 gene, actually had abnormalities in the ASXL3 gene rather than ASXL1 mutations [5].